Nevertheless, preliminary evidence showed that deoxyribonuclease I, neutrophil elastase inhibitor and blocking CXCR2 or TLR9 could restrain the progression of DLBCL [68]. This evidence concerns the gene CXCR2 and diffuse large B-cell lymphoma.